While this work was under revision, an independent basic and clinical study revealed that an immune-enhancing subset of neutrophils with a potent anti-tumor effect is conserved both in murine and human system, with a key signature of elevated Ly6A/E (Benguigui et al, 2024). Here, LY6S is linked to neoplasm.